HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 829-840 of 1,811
Drug study icon
CompletedEUCTR 2006-001471-37

A Randomized, Double-Blind Comparison of Atomoxetine versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
ADHDHistorical research record
Countries
Germany
Sponsor
Lilly Deutschland GmbH, Teichweg 3, 35396 Gießen
Drug study icon
Recruitment unclearEUCTR 2013-003888-59

ADHD: Medication or Meditation?

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Netherlands
ADHDHistorical research record
Countries
Netherlands
Sponsor
University of Amsterdam
Drug study icon
Recruitment unclearEUCTR 2013-004776-35

Cross-sectional study of 24-hour ambulatory blood pressure measurements and left ventricular mass using echocardiograms in late adolescents and adults with ADHD (ADDUCE protocol WP8 (cardiovascular))

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In United Kingdom
ADHDHistorical research record
Countries
United Kingdom
Sponsor
Radboud University Medical Centre Nijmegen
Drug study icon
Recruitment unclearEUCTR 2016-002474-13

Medication Optimization for ADHD: MOVA study Implementation and evaluation of double-blind placebo-controlled titration in clinical practice

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Netherlands
ADHDHistorical research record
Countries
Netherlands
Sponsor
Innovatiefonds Zorgverzekeraars
Drug study icon
Recruitment unclearEUCTR 2022-003237-19

The difference in pharmacodynamic and pharmacokinetic profiles between Tentin and generic dexamphetamine in adults with attention deficit hyperactivity disorder, a double-blinded randomized crossov...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Netherlands
ADHDHistorical research record
Countries
Netherlands
Sponsor
Amsterdam UMC

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.